Latest news
Loading news…
BerGenBio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Bergen, Hordaland, Norway Founded 2007 11-50 employees For Profit
BerGenBio is clinical-stage biopharma developing first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
26
Ticker
BGBIO
OSE - Oslo Stock Exchange
Patents
27
14 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- BGBIO
- Exchange
- OSE - Oslo Stock Exchange
- IPO date
- Apr 6, 2017
- Raised at IPO
- $47M
- Valuation at IPO
- $98M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
- Active products
- 23
- Patents granted
- 27
- Trademarks
- 14
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $803.00
Company Info
- Founded
- 2007
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- Sub-organizations
- 1
- News articles
- 105
- HQ
- Bergen, Hordaland, Norway
- Region
- Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
- Exit date
- Apr 6, 2017
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.5
- Trend (90d)
- -0.9
- Last leadership hire
- Sep 30, 2025
Acquisitions by BerGenBio
Loading columns…
0 of 0Show
Page 1 / 1
Key People at BerGenBio
Senior Scientific Advisor
CEO
Co-Founder, CTO ,Director of Biomarkers & Assay Development
CFO
26
professional contacts at BerGenBio
Contact execs at BerGenBio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to BerGenBio
Loading news…
FAQs about BerGenBio
People who checked this page also checked these
Sectors BerGenBio invests & acquires in
Browse the full Acquirezy directory.